908 Devices Inc (MASS)
5.63
-0.02
(-0.35%)
USD |
NASDAQ |
May 06, 16:00
5.63
0.00 (0.00%)
After-Hours: 20:00
908 Devices Cash from Investing (Quarterly): -5.78M for March 31, 2024
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | -5.78M |
December 31, 2023 | 4.636M |
September 30, 2023 | -9.915M |
June 30, 2023 | -19.94M |
March 31, 2023 | -1.185M |
December 31, 2022 | -0.612M |
September 30, 2022 | -14.51M |
June 30, 2022 | -0.072M |
March 31, 2022 | -0.617M |
Date | Value |
---|---|
December 31, 2021 | -0.054M |
September 30, 2021 | -0.058M |
June 30, 2021 | -0.616M |
March 31, 2021 | -0.009M |
December 31, 2020 | 0.00 |
September 30, 2020 | 0.175M |
June 30, 2020 | -0.093M |
March 31, 2020 | -0.091M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-19.94M
Minimum
Jun 2023
4.636M
Maximum
Dec 2023
-2.867M
Average
-0.093M
Median
Jun 2020
Cash from Investing (Quarterly) Benchmarks
Perspective Therapeutics Inc | -0.089M |
Retractable Technologies Inc | -0.3478M |
Xtant Medical Holdings Inc | -2.313M |
Asensus Surgical Inc | 7.427M |
Catheter Precision Inc | -0.018M |
Cash from Investing (Quarterly) Related Metrics
Cash from Operations (Quarterly) | -9.357M |
Cash from Financing (Quarterly) | -1.295M |
Free Cash Flow | -25.53M |
Free Cash Flow Per Share (Quarterly) | -0.3137 |
Free Cash Flow to Equity (Quarterly) | -10.26M |
Free Cash Flow to Firm (Quarterly) | -10.26M |
Free Cash Flow Yield | -13.99% |